A5074778073- Obstructive Sleep Apnea Research
- Tracheal and airway disorders
- Congenital Heart Disease Studies
- Child Nutrition and Feeding Issues
- Sleep and related disorders
- Respiratory Support and Mechanisms
- Healthcare Policy and Management
- Atrial Fibrillation Management and Outcomes
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Neuroscience of respiration and sleep
- Health, Education, and Physical Culture
- Global Health Care Issues
- Medication Adherence and Compliance
- Asthma and respiratory diseases
- Diet and metabolism studies
- Pharmaceutical studies and practices
- School Health and Nursing Education
- Venous Thromboembolism Diagnosis and Management
ResMed (Netherlands)
2023-2024
ScienceMedia (United States)
2020-2024
ResMed (United States)
2020-2024
Jinnah Medical & Dental College
2024
Background Obstructive sleep apnea (OSA) is common in heart failure with preserved ejection fraction (HFpEF). However, current evidence equivocal regarding the potential benefits of treating OSA positive airway pressure (PAP) therapy HFpEF. This study assessed association between adherence to PAP and health care resource use patients Methods Results Administrative insurance claims data linked objective usage from HFpEF were used determine associations a composite outcome including...
Background Obstructive sleep apnea (OSA) is a common comorbidity in patients with heart failure, although current evidence equivocal regarding the potential benefits of treating OSA positive airway pressure (PAP) therapy failure. This study assessed impact adherence to PAP on health care resource utilization and failure reduced ejection fraction. Methods Results Administrative insurance claims data linked objective use from fraction were used determine associations between composite outcome...
Study Objectives: There is a complex interplay between obstructive sleep apnea (OSA) and type 2 diabetes.There are minimal data regarding the effects of treating OSA with positive airway pressure (PAP) therapy on outcomes health care resource utilization (HCRU) in patients diabetes.We investigated impact PAP adherence HCRU costs this population.Methods: A retrospective analysis was conducted cohort patient from US administrative claims dataset linked to objective device (AirView, ResMed...
Obstructive sleep apnea (OSA) contributes to the generation, recurrence, and perpetuation of atrial fibrillation, it is associated with worse outcomes. Little known about economic impact OSA therapy in fibrillation. This retrospective cohort study assessed positive airway pressure (PAP) adherence on health care resource use costs patients
Background: Pulmonary embolism (PE) presents great acute danger and its chronic effects on cardiovascular organization is an important, however investigated aspect. People who survive PE subjected to higher vulnerability develop long-term diseases including heart failure as well pulmonary hypertension also exhibit hospital admission rates. It therefore important grasp these risks in effort get the best out of treatment patients. Objectives: The current meta-analysis has been designed look at...
Abstract Introduction Insomnia and obstructive sleep apnea (OSA), comorbidly known as COMISA, are the two most common disorders, with each impairing treatment efficacy for other. Real-world studies on of patients COMISA lacking, thus this study aimed to examine clinical economic impact treating OSA positive airway pressure (PAP) therapy in population. Methods This retrospective linked administrative claims data PAP device usage newly diagnosed initiating (index date) between January 2015...
Abstract Introduction Obstructive sleep apnea (OSA) and obesity are strongly associated highly prevalent in the United States (US). Routine treatment for OSA often includes positive airway pressure (PAP) therapy combined with weight management strategies, more recently including use of glucagon-like peptide 1 (GLP-1) receptor agonists. This real-world analysis assessed impact recent GLP-1 on PAP over year non-diabetic patients PAP-treated obesity. Methods Administrative claims data from...
Abstract Introduction Obesity is a modifiable risk factor for obstructive sleep apnea (OSA). Weight management interventions have been shown to reduce OSA symptoms and severity some patients. This retrospective analysis aimed evaluate the impact of weight reduction surgery or procedure (WRS/P) on pressure changes in positive airway (PAP) treated patients as proxy following surgery. Methods We analyzed administrative claims data from 2015 2021 adult (≥18 years) linked PAP device data. The...
Introduction: Obstructive sleep apnea (OSA) is common in heart failure, although the impact of OSA treatment remains unclear. We assessed association between adherence to positive airway pressure (PAP) therapy and healthcare resource utilization patients with failure reduced ejection fraction (HFrEF). Methods: Administrative insurance claims data linked objective PAP usage from HFrEF were used measure a composite clinical outcome hospitalization emergency room (ER) visits. US Medicare...
Abstract Introduction Although diastolic heart failure (HFpEF) patients frequently have comorbid obstructive sleep apnea (OSA), which has been associated with poor prognosis, the impact of positive airway pressure (PAP) therapy remains unclear. This retrospective study sought to investigate association between 1 year adherence PAP and healthcare resource utilization (HCRU) in newly diagnosed OSA HFpEF. Methods A national sample administrative claims data linked objective usage was used for...
Abstract Introduction The prevalence of obstructive sleep apnea (OSA) is high in patients with systolic heart failure (HFrEF) and has been associated poor prognosis this patient population. impact positive airway pressure (PAP) therapy OSA HFrEF remains unclear. This retrospective study sought to investigate the association between 1-year adherence PAP healthcare resource utilization (HCRU) newly diagnosed comorbid HFrEF. Methods A national sample administrative claims data linked objective...
Introduction: The prevalence of obstructive sleep apnea (OSA) in heart failure (HF) patients varies from 30 to 50%. differences clinical characteristics, healthcare resource utilization (HCRU), and positive airway pressure (PAP) usage between HF with preserved ejection fraction (HFpEF) vs. reduced (HFrEF) OSA are not well known. Objective: To compare PAP usage, HCRU HFpEF vs HFrEF. Methods: Retrospective cohort study using US administrative claims data linked objective over one year. HFrEF...
Introduction: Heart failure patients with preserved ejection fraction (HFpEF) frequently have co-morbid obstructive sleep apnea (OSA), although the impact of OSA treatment remains unclear in this patient population. We assessed association between adherence to positive airway pressure (PAP) therapy and healthcare resource utilization HFpEF. Methods: Administrative insurance claims data linked objective PAP usage from HFpEF were used measure utilization, defined by hospitalizations emergency...